| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
INSERM, U-427 (J.L.F., A.T., D.B.-E.), Laboratoire de Génétique Moléculaire (M.V., Y.G.), Centre National de la Recherche Scientifique (D.B.), UPRES-A 8067, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes, 75270 Paris, France; Service dHormonologie (J.G., D.P.) and Service de Gynécologie Obstétrique (D.L., P.B.), Hôpital Robert Debré, 75019 Paris, France; and Service de Biochimie, Hôpital Ambroise Paré (F.M.), 92104 Boulogne, France
Address all correspondence and requests for reprints to: Dr. D. Evain-Brion, INSERM U-427, Faculté des Sciences Pharmaceutiques et Biologiques, 4 avenue de lObservatoire, 75270 Paris Cedex 06, France. E-mail: evain{at}pharmacie.univ-paris5.fr
The syncytiotrophoblast (ST) is one of the major components of the human placenta, as it is involved in feto-maternal exchanges and the secretion of pregnancy-specific hormones. The aim of this study was to elucidate the formation and function of the ST in trisomy 21 (Downs syndrome). We first used the in vitro model of cytotrophoblast differentiation into ST. Cytotrophoblasts were isolated from 15 trisomy 21-affected placentas (1235 weeks gestation) and 10 gestational age-matched control placentas. In vitro cytotrophoblasts isolated from normal placenta fused to form the ST. This was associated with an increase in transcript levels and in the secretion of hCG, human placental lactogen, placental GH, and leptin. In trisomy 21-affected placentas, we observed a defect (or a delay) in ST formation and a dramatic decrease in the synthesis and secretion of these hormones compared to those in cultured cells isolated from control age-matched placentas. These results were confirmed by a significant (P < 0.001) decrease in gene expression in total homogenates of trisomy 21-affected placentas compared to controls. These results will be of help in understanding the maternal hormonal markers of fetal trisomy 21 and the consequences of placental defects for fetal development.
This article has been cited by other articles:
![]() |
G. Pidoux, P. Gerbaud, O. Marpeau, J. Guibourdenche, F. Ferreira, J. Badet, D. Evain-Brion, and J.-L. Frendo Human Placental Development Is Impaired by Abnormal Human Chorionic Gonadotropin Signaling in Trisomy 21 Pregnancies Endocrinology, November 1, 2007; 148(11): 5403 - 5413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Handschuh, J. Guibourdenche, V. Tsatsaris, M. Guesnon, I. Laurendeau, D. Evain-Brion, and T. Fournier Human Chorionic Gonadotropin Produced by the Invasive Trophoblast But Not the Villous Trophoblast Promotes Cell Invasion and Is Down-Regulated by Peroxisome Proliferator-Activated Receptor-{gamma} Endocrinology, October 1, 2007; 148(10): 5011 - 5019. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roper, H. K. St. John, J. Philip, A. Lawler, and R. H. Reeves Perinatal Loss of Ts65Dn Down Syndrome Mice Genetics, January 1, 2006; 172(1): 437 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.N. Weinans, U. Sancken, R. Pandian, J. M.W. van de Ouweland, H. W.A. de Bruijn, J. P. Holm, and A. Mantingh Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) as a First-Trimester Serum Marker for Down Syndrome Clin. Chem., July 1, 2005; 51(7): 1276 - 1279. [Full Text] [PDF] |
||||
![]() |
A. T.J.I. Go, A. Visser, M. A.M. Mulders, M. A. Blankenstein, J. M.G. van Vugt, and C. B.M. Oudejans Detection of Placental Transcription Factor mRNA in Maternal Plasma Clin. Chem., August 1, 2004; 50(8): 1413 - 1414. [Full Text] [PDF] |
||||
![]() |
J.-L. Frendo, J. Guibourdenche, G. Pidoux, M. Vidaud, D. Luton, Y. Giovangrandi, D. Porquet, F. Muller, and D. Evain-Brion Trophoblast Production of a Weakly Bioactive Human Chorionic Gonadotropin in Trisomy 21-Affected Pregnancy J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 727 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chellakooty, K. Vangsgaard, T. Larsen, T. Scheike, J. Falck-Larsen, J. Legarth, A. M. Andersson, K. M. Main, N. E. Skakkebaek, and A. Juul A Longitudinal Study of Intrauterine Growth and the Placental Growth Hormone (GH)-Insulin-Like Growth Factor I Axis in Maternal Circulation: Association between Placental GH and Fetal Growth J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 384 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blaise, N. de Parseval, L. Benit, and T. Heidmann Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution PNAS, October 28, 2003; 100(22): 13013 - 13018. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Frendo, L. Cronier, G. Bertin, J. Guibourdenche, M. Vidaud, D. Evain-Brion, and A. Malassine Involvement of connexin 43 in human trophoblast cell fusion and differentiation J. Cell Sci., August 15, 2003; 116(16): 3413 - 3421. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pavan, A. Tarrade, A. Hermouet, C. Delouis, M. Titeux, M. Vidaud, P. Therond, D. Evain-Brion, and T. Fournier Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPAR{gamma} in cell invasion process Carcinogenesis, August 1, 2003; 24(8): 1325 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Smallwood, A. Papageorghiou, K. Nicolaides, M.K.R. Alley, A. Jim, G. Nargund, K. Ojha, S. Campbell, and S. Banerjee Temporal Regulation of the Expression of Syncytin (HERV-W), Maternally Imprinted PEG10, and SGCE in Human Placenta Biol Reprod, July 1, 2003; 69(1): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Costa, A. Benachi, M. Olivi, Y. Dumez, M. Vidaud, and E. Gautier Fetal Expressed Gene Analysis in Maternal Blood: A New Tool for Noninvasive Study of the Fetus Clin. Chem., June 1, 2003; 49(6): 981 - 983. [Full Text] [PDF] |
||||
![]() |
J.-L. Frendo, D. Olivier, V. Cheynet, J.-L. Blond, O. Bouton, M. Vidaud, M. Rabreau, D. Evain-Brion, and F. Mallet Direct Involvement of HERV-W Env Glycoprotein in Human Trophoblast Cell Fusion and Differentiation Mol. Cell. Biol., May 15, 2003; 23(10): 3566 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pandian, J. Lu, and J. Ossolinska-Plewnia Fully Automated Chemiluminometric Assay for Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen) Clin. Chem., May 1, 2003; 49(5): 808 - 810. [Full Text] [PDF] |
||||
![]() |
M. Yang, Z. M. Lei, and Ch. V. Rao The Central Role of Human Chorionic Gonadotropin in the Formation of Human Placental Syncytium Endocrinology, March 1, 2003; 144(3): 1108 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. FRENDO, P. THEROND, J. GUIBOURDENCHE, M. VIDAUD, and D. EVAIN-BRIONA Implication of Copper Zinc Superoxide Dismutase (SOD-1) in Human Placenta Development Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 297 - 301. [Full Text] [PDF] |
||||
![]() |
A. Tarrade, F. Goffin, C. Munaut, R. Lai-Kuen, V. Tricottet, J.-M. Foidart, M. Vidaud, F. Frankenne, and D. Evain-Brion Effect of Matrigel on Human Extravillous Trophoblasts Differentiation: Modulation of Protease Pattern Gene Expression Biol Reprod, November 1, 2002; 67(5): 1628 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Debieve and K. Thomas Control of the human inhibin {alpha} chain promoter in cytotrophoblast cells differentiating into syncytium Mol. Hum. Reprod., March 1, 2002; 8(3): 262 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tarrade, K. Schoonjans, L. Pavan, J. Auwerx, C. Rochette-Egly, D. Evain-Brion, and T. Fournier PPAR{gamma}/RXR{alpha} Heterodimers Control Human Trophoblast Invasion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5017 - 5024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tarrade, K. Schoonjans, J. Guibourdenche, J. M. Bidart, M. Vidaud, J. Auwerx, C. Rochette-Egly, and D. Evain-Brion PPAR{gamma}/RXR{alpha} Heterodimers Are Involved in Human CG{beta} Synthesis and Human Trophoblast Differentiation Endocrinology, October 1, 2001; 142(10): 4504 - 4514. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Debieve, A. Moiset, K. Thomas, S. Pampfer, and C. Hubinont Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies Mol. Hum. Reprod., August 1, 2001; 7(8): 765 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Frendo, P. Therond, T. Bird, N. Massin, F. Muller, J. Guibourdenche, D. Luton, M. Vidaud, W. B. Anderson, and D. Evain-Brion Overexpression of Copper Zinc Superoxide Dismutase Impairs Human Trophoblast Cell Fusion and Differentiation Endocrinology, August 1, 2001; 142(8): 3638 - 3648. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |